Boston Medical Group vs Joi + Blokes

Cost-first shoppers who want a clinician-run 12-week program and can accept a price quoted as a range rather than a rate.

Reasons to consider it

• +An established medical group with a defined 12-week program rather than an open-ended subscription
• +Public pages describe a twelve-week program and monthly shipments, but disagree on the price
• +Semaglutide is prescribed and dispensed under a compounded pathway with clinician oversight

What to weigh up

• −The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
• −The site quotes conflicting twelve-week totals: $699 on its cost page and $999 on its program-steps page, which separately names a $100 telemedicine platform fee; get a written all-in quote
• −The weight-loss landing page carries no price at all; the numbers are two pages deeper, in the FAQ and the costs page

Patients already on Joi or Blokes hormone programs who want GLP-1 added under the same clinician relationship, and are comfortable with a 3-month billing commitment.

Reasons to consider it

• +Named Medical Director, Dr. Melissa Loseke, DO, plus a named Head Nurse Practitioner and two named Medical Advisors, more clinical names than most programs we track
• +Separate gender-specific programs (Joi for women, Blokes for men) built around hormone health, with GLP-1 added as an integrated option alongside testosterone/perimenopause protocols
• +For FDA-approved GLP-1/GIP medications specifically, insurance is accepted and the prescription routes to the patient's own local pharmacy rather than a mail-order compounder

What to weigh up

• −Billed in 3-month blocks, not month-to-month — the $99/$149 first-month price is promotional, and the standing cost from month 2 is $179 (semaglutide) or $249 (tirzepatide)
• −New York and New Jersey residents are explicitly called out as paying different pricing, but the site does not state the amount
• −No full state-availability list is published — the safety page only says 'available in certain locations'

Regulatory note: the FDA issued a warning letter to Joi and Blokes dba Joi + Blokes in June 2026. We still list and link to Joi + Blokes; you should know the letter is on the public record before you decide.